焦虑敏感性和大麻使用：研究结果的系统回顾和概念化

IF 4.2 2区心理学 Q1 PSYCHOLOGY, CLINICAL

Behaviour Research and Therapy Pub Date : 2025-03-21 DOI:10.1016/j.brat.2025.104733

Nicole A. Short , Rachel Weese , Mattea Pezza , Michele A. Bedard-Gilligan

{"title":"焦虑敏感性和大麻使用：研究结果的系统回顾和概念化","authors":"Nicole A. Short , Rachel Weese , Mattea Pezza , Michele A. Bedard-Gilligan","doi":"10.1016/j.brat.2025.104733","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>Anxiety sensitivity (AS), or fear of anxious arousal, is a transdiagnostic risk factor that may be associated with greater risk for problematic cannabis use. Individuals with high AS may use cannabis to cope with distressing physiological sensations. However, there is also conflicting research suggesting that individuals with high AS may avoid cannabis use because it is perceived to cause unpleasant physiological sensations. Rates of cannabis use disorder (CUD) are high and escalating in the US, so identification and understanding of risk factors such as AS is crucial for prevention and treatment of CUD. The purpose of the current review is to summarize and critically review the, at times, conflicting existing research on AS and CUD, present a unifying conceptualization of AS as a risk factor for CUD, and establish a future research agenda.</div></div><div><h3>Methods</h3><div>Empirical studies indexed in PubMed or PsycInfo as of Spring 2024 testing associations between AS and cannabis use were included. Fifty studies were reviewed and coded by two independent coders who evaluated study characteristics and risk of bias.</div></div><div><h3>Results</h3><div>Results were qualitatively synthesized and suggested a direct association between elevated AS and greater levels of coping-oriented and possibly problematic cannabis use, but not lifetime cannabis use or cannabis use frequency.</div></div><div><h3>Discussion</h3><div>A conceptual model is presented in which high AS may lead to greater coping-oriented cannabis use, and, in turn, problematic cannabis use in the presence of symptoms of psychopathology and positive cannabis expectancies. Future research should test this model utilizing prospective and/or experimental studies with valid assessments of AS and cannabis use among diverse cannabis using samples.</div></div>","PeriodicalId":48457,"journal":{"name":"Behaviour Research and Therapy","volume":"188 ","pages":"Article 104733"},"PeriodicalIF":4.2000,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Anxiety sensitivity and cannabis use: A systematic review and conceptualization of research findings\",\"authors\":\"Nicole A. Short , Rachel Weese , Mattea Pezza , Michele A. Bedard-Gilligan\",\"doi\":\"10.1016/j.brat.2025.104733\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objectives</h3><div>Anxiety sensitivity (AS), or fear of anxious arousal, is a transdiagnostic risk factor that may be associated with greater risk for problematic cannabis use. Individuals with high AS may use cannabis to cope with distressing physiological sensations. However, there is also conflicting research suggesting that individuals with high AS may avoid cannabis use because it is perceived to cause unpleasant physiological sensations. Rates of cannabis use disorder (CUD) are high and escalating in the US, so identification and understanding of risk factors such as AS is crucial for prevention and treatment of CUD. The purpose of the current review is to summarize and critically review the, at times, conflicting existing research on AS and CUD, present a unifying conceptualization of AS as a risk factor for CUD, and establish a future research agenda.</div></div><div><h3>Methods</h3><div>Empirical studies indexed in PubMed or PsycInfo as of Spring 2024 testing associations between AS and cannabis use were included. Fifty studies were reviewed and coded by two independent coders who evaluated study characteristics and risk of bias.</div></div><div><h3>Results</h3><div>Results were qualitatively synthesized and suggested a direct association between elevated AS and greater levels of coping-oriented and possibly problematic cannabis use, but not lifetime cannabis use or cannabis use frequency.</div></div><div><h3>Discussion</h3><div>A conceptual model is presented in which high AS may lead to greater coping-oriented cannabis use, and, in turn, problematic cannabis use in the presence of symptoms of psychopathology and positive cannabis expectancies. Future research should test this model utilizing prospective and/or experimental studies with valid assessments of AS and cannabis use among diverse cannabis using samples.</div></div>\",\"PeriodicalId\":48457,\"journal\":{\"name\":\"Behaviour Research and Therapy\",\"volume\":\"188 \",\"pages\":\"Article 104733\"},\"PeriodicalIF\":4.2000,\"publicationDate\":\"2025-03-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Behaviour Research and Therapy\",\"FirstCategoryId\":\"102\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0005796725000555\",\"RegionNum\":2,\"RegionCategory\":\"心理学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PSYCHOLOGY, CLINICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Behaviour Research and Therapy","FirstCategoryId":"102","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0005796725000555","RegionNum":2,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHOLOGY, CLINICAL","Score":null,"Total":0}

引用次数: 0

摘要

焦虑敏感性（AS），或对焦虑唤醒的恐惧，是一种跨诊断风险因素，可能与问题大麻使用的更大风险相关。高AS患者可能会使用大麻来应对痛苦的生理感觉。然而，也有相互矛盾的研究表明，高AS患者可能会避免使用大麻，因为它被认为会引起不愉快的生理感觉。在美国，大麻使用障碍（CUD）的发病率很高，而且还在不断上升，因此识别和了解as等风险因素对预防和治疗CUD至关重要。当前回顾的目的是总结和批判性回顾，有时，关于AS和CUD的相互冲突的现有研究，提出一个统一的AS作为CUD风险因素的概念，并建立未来的研究议程。方法纳入截至2024年春季PubMed或PsycInfo检索的临床研究，测试as与大麻使用之间的关系。50项研究由两名独立编码员进行审查和编码，他们评估研究特征和偏倚风险。结果定性综合结果表明，AS升高与应对导向和可能有问题的大麻使用水平之间存在直接关联，但与终身大麻使用或大麻使用频率无关。讨论提出了一个概念模型，其中高AS可能导致更多的以应对为导向的大麻使用，反过来，在存在精神病理症状和积极的大麻预期的情况下，有问题的大麻使用。未来的研究应该利用前瞻性和/或实验性研究来测试这一模型，并对不同大麻使用样本中的AS和大麻使用进行有效评估。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Anxiety sensitivity and cannabis use: A systematic review and conceptualization of research findings

Objectives

Anxiety sensitivity (AS), or fear of anxious arousal, is a transdiagnostic risk factor that may be associated with greater risk for problematic cannabis use. Individuals with high AS may use cannabis to cope with distressing physiological sensations. However, there is also conflicting research suggesting that individuals with high AS may avoid cannabis use because it is perceived to cause unpleasant physiological sensations. Rates of cannabis use disorder (CUD) are high and escalating in the US, so identification and understanding of risk factors such as AS is crucial for prevention and treatment of CUD. The purpose of the current review is to summarize and critically review the, at times, conflicting existing research on AS and CUD, present a unifying conceptualization of AS as a risk factor for CUD, and establish a future research agenda.

Methods

Empirical studies indexed in PubMed or PsycInfo as of Spring 2024 testing associations between AS and cannabis use were included. Fifty studies were reviewed and coded by two independent coders who evaluated study characteristics and risk of bias.

Results

Results were qualitatively synthesized and suggested a direct association between elevated AS and greater levels of coping-oriented and possibly problematic cannabis use, but not lifetime cannabis use or cannabis use frequency.

Discussion

A conceptual model is presented in which high AS may lead to greater coping-oriented cannabis use, and, in turn, problematic cannabis use in the presence of symptoms of psychopathology and positive cannabis expectancies. Future research should test this model utilizing prospective and/or experimental studies with valid assessments of AS and cannabis use among diverse cannabis using samples.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Behaviour Research and Therapy PSYCHOLOGY, CLINICAL-

CiteScore

7.50

自引率

7.30%

发文量

148

期刊介绍： The major focus of Behaviour Research and Therapy is an experimental psychopathology approach to understanding emotional and behavioral disorders and their prevention and treatment, using cognitive, behavioral, and psychophysiological (including neural) methods and models. This includes laboratory-based experimental studies with healthy, at risk and subclinical individuals that inform clinical application as well as studies with clinically severe samples. The following types of submissions are encouraged: theoretical reviews of mechanisms that contribute to psychopathology and that offer new treatment targets; tests of novel, mechanistically focused psychological interventions, especially ones that include theory-driven or experimentally-derived predictors, moderators and mediators; and innovations in dissemination and implementation of evidence-based practices into clinical practice in psychology and associated fields, especially those that target underlying mechanisms or focus on novel approaches to treatment delivery. In addition to traditional psychological disorders, the scope of the journal includes behavioural medicine (e.g., chronic pain). The journal will not consider manuscripts dealing primarily with measurement, psychometric analyses, and personality assessment.